Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research Society

Archive ouverte

Dierssen, Mara | Herault, Yann | Helguera, Pablo | Martínez de Lagran, Maria | Vazquez, Anna | Christian, Bradley | Carmona-Iragui, Maria | Wiseman, Frances | Mobley, William | Fisher, Elizabeth M.C. | Brault, Veronique | Esbensen, Anna | Jacola, Lisa | Potier, Marie Claude | Hamlett, Eric | Abbeduto, Leonard | del Hoyo Soriano, Laura | Busciglio, Jorge | Iulita, Maria Florencia | Crispino, John | Malinge, Sébastien | Barone, Eugenio | Perluigi, Marzia | Costanzo, Floriana | Delabar, Jean Maurice | Bartesaghi, Renata | Dekker, Alain | de Deyn, Peter | Fortea Ormaechea, Juan | Shaw, Patricia | Haydar, Tarik | Sherman, Stephanie | Strydom, André | Bhattacharyya, Anita

Edité par CCSD ; Karger -

International audience. Research focused on Down syndrome has increased in the last several years to advance understanding of the consequences of trisomy 21 (T21) on molecular and cellular processes and, ultimately, on individuals with Down syndrome. The Trisomy 21 Research Society (T21RS) is the premier scientific organization for researchers and clinicians studying Down syndrome. The Third International Conference of T21RS, held June 6–9, 2019, in Barcelona, Spain, brought together 429 scientists, families, and industry representatives to share the latest discoveries on underlying cellular and molecular mechanisms of T21, define cognitive and behavioral challenges and better understand comorbidities associated with Down syndrome, including Alzheimer’s disease and leukemia. Presentation of cutting-edge results in neuroscience, neurology, model systems, psychology, cancer, biomarkers and molecular and phar­ma­cological therapeutic approaches demonstrate the compelling interest and continuing advancement in all aspects of understanding and ameliorating conditions associated with T21.

Consulter en ligne

Suggestions

Du même auteur

Paving the Way for Therapy: The Second International Conference of the Trisomy 21 Research Society

Archive ouverte | Reeves, Roger | CCSD

International audience. In the last decade, a number of important research advances in different fields have allowed Down syndrome (DS) research to flourish, creating a time of both unparalleled opportunity and cons...

Translating molecular advances in Down syndrome and Fragile X syndrome into therapies

Archive ouverte | Faundez, Victor | CCSD

International audience

Innovating Therapies for Down Syndrome: An International Virtual Conference of the T21 Research Society

Archive ouverte | Hamlett, Eric, D | CCSD

International audience. Research focused on Down syndrome continued to gain momentum in the last several years and is advancing our understanding of how trisomy 21 (T21) modifies molecular and cellular processes. Th...

Chargement des enrichissements...